Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alex R. Rinehart"'
Autor:
Jayvant Heera, Srinivas Rao Valluri, Silvia Nozza, Hans Jürgen Stellbrink, Geoffrey Mukwaya, Annie F. Fang, Lynn McFadyen, Eric L E Fevre, Charles Craig, Alex R. Rinehart, Michael S. Saag, Manoli Vourvahis, Andrew Clark, Andrew Carr, Carl J. Fichtenbaum
Publikováno v:
AIDS (London, England)
Objective The aim of this study was to evaluate the efficacy of maraviroc along with darunavir/ritonavir, all once daily, for the treatment of antiretroviral-naive HIV-1 infected individuals. Design MODERN was a multicentre, double-blind, noninferior
Autor:
Monika Peeters, Heidy Muller, Adriano Lazzarin, Keikawus Arastéh, Nathan Clumeck, Alex R. Rinehart, Eric Lefebvre, Sandra De Meyer, Anton Pozniak
Publikováno v:
Scopus-Elsevier
To evaluate antiviral activity, tolerability, and safety of the protease inhibitor (PI) TMC114 boosted with low-dose ritonavir (RTV).A randomized, open-label, controlled, phase IIA clinical trial in 15 sites in Europe with 50 HIV-1-infected patients
Autor:
Monika Peeters, Gerben van 't Klooster, Patricia Baede-Van Dijk, Alex R. Rinehart, Karin de Dier, Alexey Yakovlev, A Rakhmanova, Boris Gruzdev, Wim Parys, Ekaterina Doubovskaya
Publikováno v:
AIDS. 17:2487-2494
Objective: To evaluate antiviral activity tolerability safety and pharmacokinetics of treatment with TMC125 (a non-nucleoside reverse transcriptase inhibitor) 900 mg twice daily for 7 days. Design: Randomized double-blind placebo-controlled phase IIA
Autor:
Susan Hunt, Calvin J. Cohen, Jeffrey P. Nadler, Allan Stein, Martin Markowitz, Neil M.H. Graham, Douglas L. Mayers, Steven Davis, Shannon Schrader, W. Keith Henry, Charles Farthing, Michael Sension, Stephen Brown, Werner Verbiest, Kurt Hertogs, Deborah Copeland, Harold A. Kessler, Richard Stryker, Melanie A. Thompson, Michael S. Saag, Michael H. Ames, Carol L. Brosgart, Gabriel Torres, Susan Jacobson, Jeffrey Goodgame, Howard Grossman, Marcus A. Conant, Ann C. Collier, Alex R. Rinehart, Jeffrey Galpin, Roberto C. Arduino
Publikováno v:
AIDS. 16:579-588
Objective To compare the effect of treatment decisions guided by phenotypic resistance testing (PRT) or standard of care (SOC) on short-term virological response. Design A prospective, randomized, controlled clinical trial conducted in 25 university